Spots Global Cancer Trial Database for testicular choriocarcinoma and teratoma
Every month we try and update this database with for testicular choriocarcinoma and teratoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer | NCT00004077 | Testicular Germ... | cisplatin ifosfamide paclitaxel | 16 Years - 64 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer | NCT00003941 | Mediastinal Can... Metastatic Canc... Testicular Germ... | bleomycin sulfa... filgrastim cisplatin etoposide ifosfamide bone marrow abl... peripheral bloo... | 16 Years - 50 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment | NCT00453310 | Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | sunitinib malat... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors | NCT00301782 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... carboplatin cisplatin etoposide phosp... vincristine sul... | 16 Years - | National Cancer Institute (NCI) | |
| Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors | NCT00432094 | Childhood Germ ... Ovarian Cancer Teratoma | carboplatin etoposide ifosfamide paclitaxel thiotepa autologous hema... Mesna filgrastim | 10 Years - 69 Years | Masonic Cancer Center, University of Minnesota | |
| Combination Chemotherapy in Treating Men With Germ Cell Cancer | NCT00003643 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... filgrastim cisplatin etoposide paclitaxel | 16 Years - 50 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors | NCT00070096 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ... | ixabepilone | 16 Years - | National Cancer Institute (NCI) | |
| Diagnostic Study of Patients With Stage I Testicular Cancer | NCT00003800 | Testicular Germ... | immunohistochem... laboratory biom... radionuclide im... | 15 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors | NCT00453232 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... pegfilgrastim cisplatin etoposide | 18 Years - 40 Years | National Cancer Institute (NCI) | |
| Positron Emission Tomography in Detecting Testicle Cancer | NCT00045045 | Testicular Germ... | positron emissi... fludeoxyglucose... | - | National Cancer Institute (NCI) | |
| Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer | NCT00060372 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Atypical Chroni... Childhood Myelo... Chronic Myeloge... Disseminated Ne... Malignant Neopl... Ovarian Chorioc... Ovarian Embryon... Ovarian Immatur... Ovarian Mature ... Ovarian Mixed G... Ovarian Monoder... Ovarian Polyemb... Ovarian Yolk Sa... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Malig... Recurrent Mantl... Recurrent Neuro... Recurrent Ovari... Recurrent Ovari... Refractory Chro... Refractory Mult... Relapsing Chron... Stage I Multipl... Stage II Multip... Stage II Ovaria... Stage III Malig... Stage III Multi... Stage III Ovari... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Ovaria... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Tera... Testicular Yolk... Testicular Yolk... Testicular Yolk... | ipilimumab therapeutic all... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer | NCT00002931 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | filgrastim carboplatin etoposide ifosfamide paclitaxel autologous bone... bone marrow abl... | 16 Years - 120 Years | City of Hope Medical Center | |
| Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors | NCT00072215 | Extragonadal Ge... Testicular Germ... | cisplatin ifosfamide paclitaxel vinblastine | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors | NCT00070096 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ... | ixabepilone | 16 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors | NCT00470366 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | pegfilgrastim cisplatin ifosfamide paclitaxel | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Men With Germ Cell Cancer | NCT00003643 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... filgrastim cisplatin etoposide paclitaxel | 16 Years - 50 Years | European Organisation for Research and Treatment of Cancer - EORTC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
